Dracula's children may lead to novel drug design

Dracula’s children may lead to novel drug design

(Phys.org) —Vampire bat venom could hold the key to new treatments for stroke and high blood pressure.

An international team of scientists led by UQ's Associate Professor Bryan Fry from the School of Biological Sciences has discovered that vampire bat venom contains molecules capable of evading the victim's immune system.

"Our team's results point to entirely new forms of in the venom, as well as novel molecules that cause dilation of the small arteries near the skin," Associate Professor Fry said.

"Just as has developed rapidly to stay ahead of evolving resistance in prey, are rapidly evolving their venom to prevent the immune system of the prey from generating antibodies against the venom molecules."

Associate Professor Fry said vampire bats secreted multiple forms of the same , with myriad tiny changes scattered across the surface of the molecule.

"This means that even if an antibody is generated against one molecule, there are a number of other ones that will sneak past the prey's defence system and keep the blood flowing.

"This means the same victim can be fed on night after night.

"The discovery reveals a vast array of novel molecules, which have tremendous potential to yield new treatments for stroke and ."

The study's findings are published in the Journal of Proteomics.


Explore further

Python venom traces could waste antivenom

More information: www.sciencedirect.com/science/ … ii/S1874391913003102
Citation: Dracula's children may lead to novel drug design (2013, June 20) retrieved 25 August 2019 from https://phys.org/news/2013-06-dracula-children-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more